Bright Minds Biosciences Inc.

DRUG | NASDAQ

Price Alert Chart Builder DCF Calculator

$61.44

+$1.98 (+3.33%)

Sep 22, 2026, 12:23 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Sep 29, 2025	FY 2024 Sep 29, 2024	FY 2023 Sep 29, 2023	FY 2022 Sep 29, 2022	FY 2021 Sep 29, 2021	FY 2020 Sep 29, 2020
Cash & Equivalents	82.91M	5.72M	6.75M	11.63M	19.76M	799.93K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	33.68K	1K
Other Long-Term Assets	n/a	n/a	n/a	0	-33.68K	-1K
Receivables	413.07K	50.22K	36.98K	155.78K	110.15K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	84.31M	5.99M	6.81M	11.95M	20.04M	878.22K
Property-Plant & Equipment	111.97K	117.66K	66.41K	138.86K	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	2K	2K
Total Long-Term Assets	111.97K	117.66K	66.41K	138.86K	2K	2K
Total Assets	84.42M	6.1M	6.88M	12.09M	20.04M	880.22K
Account Payables	1.71M	407.55K	182.31K	1.25M	596.57K	138.42K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	2.34M	528.68K	280.86K	1.47M	638.57K	150.92K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	41.25K	39.58K	n/a	71.98K	n/a	n/a
Total Liabilities	2.38M	568.26K	280.86K	1.54M	638.57K	150.92K
Total Debt	125.78K	118.96K	73.55K	139.91K	n/a	n/a
Book Value	82.04M	5.54M	6.6M	10.54M	19.4M	729.29K
Book Value Per Share	11.93	1.28	1.77	4.27	10.81	0.57
Common Stock	123.25M	35.42M	33.91M	32.24M	27.08M	980.66K
Retained Earnings	-46.58M	-34.35M	-31.55M	-24.17M	-9.21M	-559.09K
Comprehensive Income	5.37M	4.01M	3.4M	2.48M	1.57M	161.3K
Shareholders Equity	82.04M	5.54M	6.6M	10.54M	19.4M	729.29K
Total Investments	n/a	n/a	n/a	n/a	33.68K	1K